NCT03330054 is a clinical trial of fundoscope in Eye Diseases, sponsored by Mohammed Ramadan Abdallah.

Who is sponsoring NCT03330054?

NCT03330054 is sponsored by Mohammed Ramadan Abdallah.

What drugs are being tested in NCT03330054?

Interventions in NCT03330054: fundoscope.

What condition does NCT03330054 study?

NCT03330054 studies Eye Diseases, Renal Impairment, Type2 Diabetes.

Is NCT03330054 still recruiting?

NCT03330054 is currently status unknown. Last updated 7 November 2017.

Last reviewed 2017-11-07 · How we verify

NCT03330054

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Frequency Of Eye Problems In Type 2 Diabetes With Chronic Kidney Disease

Status unknown Last updated 7 November 2017

What this trial tests

trial testing fundoscope in Eye Diseases in 100 participants. Status unknown.

Timeline

1 December 2017

Primary endpoint
1 May 2018

1 June 2018

Quick facts

Lead sponsor	Mohammed Ramadan Abdallah
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	100
Start date	1 December 2017
Primary completion	1 May 2018
Estimated completion	1 June 2018

Drugs / interventions tested

fundoscope

Conditions studied

Eye Diseases — all drugs for Eye Diseases →
Renal Impairment — all drugs for Renal Impairment →
Type2 Diabetes — all drugs for Type2 Diabetes →

Sponsor

Mohammed Ramadan Abdallah

Who can join

Eligibility, any sex, with Eye Diseases or Renal Impairment. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluate the frequency and type of eye problem among Type 2 Diabetics with renal impairment and effect of renal impairment and haemodialysis on diabetic retinopathy

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Eye Diseases

Currently open trials in the same condition.

NCT07322302 — RESTORE: Comparing Two Approaches to Repeat TT Surgery Performed by Integrated Eye Care Workers (IECWs) · NA · recruiting
NCT07228793 — Natural History Study of Patients With EYS-Associated RP · recruiting
NCT07266948 — Impact of TRYPTYR on a Patient's Quality of Life and Ability to Perform Work · Phase 4 · recruiting
NCT06812845 — Patterns of Eye Diseases Among Patients Attending The Eye Investigation Unit of Sohag University Hospital · recruiting
NCT06601101 — Effects of Topical Insulin on Corneal Epithelium Healing After Corneal Crosslinking in Patients With Keratoconus · Phase 3 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03330054 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Mohammed Ramadan Abdallah
Last refreshed: 7 November 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03330054.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing